EyePoint (EYPT) Net Margin (2010 - 2026)
EyePoint (EYPT) reported Net Margin of 17270.26% for Q1 2026, down 1705591.0% on a YoY basis from N/an in Q1 2025, and down 58.37% sequentially from 10904.68% in Q4 2025.
EyePoint (EYPT) Net Margin (2010 - 2026) Analysis & Trends
EyePoint (EYPT) has 17 years of Net Margin data on file, last reported at 17270.26% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 1705591.0% year-over-year to 17270.26%; the trailing twelve-month figure through Mar 2026 stood at 4031.1% (down 375630.0% YoY), and the FY2025 full-year result was 739.42%, down 43699.0% from the prior year.
- Net Margin retreated to 17270.26% in Q1 2026, from 10904.68% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 116.42% in Q4 2023 to a low of 17270.26% in Q1 2026.
- A 5-year average of 2398.37% and a median of 384.7% in 2023 frame the typical range for Net Margin.
- Across the five-year window, Net Margin surged 74030 bps in 2023 and tumbled 1705591 bps in 2026, its largest moves.
- Tracing EYPT's Net Margin over 5 years: stood at 421.37% in 2022, then soared by 72 bps to 116.42% in 2023, then tumbled by 207 bps to 357.26% in 2024, then sank by 2952 bps to 10904.68% in 2025, then plunged by 58 bps to 17270.26% in 2026.
- Business Quant data shows EYPT's Net Margin at 17270.26% in Q1 2026, 10904.68% in Q4 2025, and 6183.44% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | -17,270.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17,270.26% |
| Dec 31, 2025 | -10,904.68% |
| Sep 30, 2025 | -6,183.44% |
| Jun 30, 2025 | -1,114.31% |
| Mar 31, 2025 | -214.35% |
| Dec 31, 2024 | -357.26% |
| Sep 30, 2024 | -278.99% |
| Jun 30, 2024 | -325.27% |
| Mar 31, 2024 | -839.52% |
| Dec 31, 2023 | -116.42% |
| Sep 30, 2023 | -163.37% |
| Jun 30, 2023 | -384.70% |
| Mar 31, 2023 | -290.37% |
| Dec 31, 2022 | -421.37% |
| Sep 30, 2022 | -903.68% |
| Jun 30, 2022 | -794.17% |
| Mar 31, 2022 | -210.15% |
| Dec 31, 2021 | -172.59% |
| Sep 30, 2021 | -184.36% |
| Jun 30, 2021 | -137.08% |